Repurposed Drugs Needed for COVID-19, according to Journal of American Physicians and Surgeons A heavily politicized process suppressed the use of safe, affordable, repurposed drugs such as hydroxychoroquine for early treatment of COVID.

Relmada Therapeutics Set for Busy 2015 in Clinical Trials Developing Drugs for the Lucrative Pain Market NEW YORK, NY--(Marketwired - April 02, 2015) - Relmada Therapeutics, Inc. (OTCQB: RLMD) has quite a busy 2015 ahead of it in the clinic. The pharmaceutical company has stepped up its work in a big...